10-Q
NABI BIOPHARMACEUTICALS FORM 10-Q 06/29/02
- Company
- Vaxart, Inc.
- Filed
- August 12, 2002
- Period of Report
- June 29, 2002
- Accession Number
- 0000950144-02-008291
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →